wordpress blog stats
Connect with us

Hi, what are you looking for?

Flipkart to acquire majority stake in SastaSundar.com and enter online healthcare despite regulatory uncertainty

The lack of well-defined regulations casts a shadow on the e-commerce platform’s decision.

flipkart online health care

Flipkart is entering the online healthcare sector through its new vertical Flipkart Health+ and is acquiring a majority stake in online pharmacy and digital healthcare platform SastaSundar.com as part of this development, the company said in a press release.

The Walmart-backed e-commerce platform is the latest to enter the crowded online healthcare space despite the regulatory uncertainty around the sector. Reliance acquired a majority stake in NetMeds last August and Tata acquired a majority stake in 1mg in June this year. Meanwhile, Flipkart’s rival Amazon launched its online pharmacy in Bangalore in August last year and has since expanded to the whole of Karnataka and Delhi.

Leveraging Flipkart’s pan-India reach and technology capabilities and SastaSundar’s deep expertise in healthcare, Flipkart Health+ will offer affordable healthcare starting with e-pharmacy and expanding to other healthcare services such as e-diagnostics and e-consultation over time, the company said in its announcement.

“This new venture builds on the Flipkart Group’s efforts to address the growing consumer internet ecosystem, providing end-to-end offerings from travel to healthcare as digital technologies continue to democratize access to products and services.” – Flipkart

Sector growing despite the lack of regulatory certainty

Just last week, in a letter to the Securities and Exchange Board of India (SEBI), Delhi-based South Chemists and Distributors Association (SCDA) has asked the regulator to reject the initial public offering (IPO) of PharmEasy, one of India’s largest online pharmacies, on the grounds that online pharmacies are not legal under Indian law.

The Delhi High Court and Madras High Court in 2018 had both passed orders prohibiting the online sale of medicines without a license. However, the Madras High Court stayed its order in 2019 after PharmEasy argued that it acts as an intermediary to connect customers with registered retail pharmacies and that it does not stock, sell or distribute any drugs, but merely provides delivery services. SastaSundar works in a similar model to PharmEasy by not maintaining its own inventory.

Advertisement. Scroll to continue reading.

SCDA had also previously written to the Competition Commission of India (CCI) objecting to PharmEasy’s merger with MedLife and Reliance’s acquisition of NetMeds. But CCI approved both the deals anyway, offering some confidence to Flipkart, which will also need CCI approval for its SastaSundar acquisition.

The government in August 2018 published a draft policy to regulate e-pharmacies, but these are yet to be finalised, leaving this sector fraught with regulatory uncertainty.

What is SastaSundar.com?

Launched in 2013, SastaSundar.com partners with more than 490 pharmacies across India to provide home delivery of medicine. The platform also runs a health blog and provides other healthcare-related features like a medicine tracker, generic drug name finder, and symptoms checker.

Along with medicines, SastaSundar also sells health foods, home care products, wellness devices, ayurvedic medicines, and beauty and personal care products. But following the Flipkart acquisition, it is not clear if these services will continue to exist considering that Flipkart primarily deals in these sectors as well.

“At SastaSundar.com we are focused on developing innovative ways to provide access to affordable healthcare easily and conveniently, building a trusted network for authentic medicines, diagnostics and wellness. Through this partnership with Flipkart, we see an opportunity to further grow and reach a larger consumer base, using complementary technologies and logistics infrastructure.” – B.L.Mittal, Founder and Chairman, SastaSundar Healthbuddy Ltd

While we do not know the size of the acquisition, SastaSundar had told The Economic Times in May that it was valued at $100 million.

Also Read

Advertisement. Scroll to continue reading.

Written By

MediaNama’s mission is to help build a digital ecosystem which is open, fair, global and competitive.



Looking at the definition of health data, it is difficult to verify whether health IDs are covered by the Bill.


The accession to the Convention brings many advantages, but it could complicate the Brazilian stance at the BRICS and UN levels.


In light of the state's emerging digital healthcare apparatus, how does Clause 12 alter the consent and purpose limitation model?


The collective implication of leaving out ‘proportionality’ from Clause 12 is to provide very wide discretionary powers to the state.


The latest draft is also problematic for companies or service providers that have nothing to with children's data.

You May Also Like


Google has released a Google Travel Trends Report which states that branded budget hotel search queries grew 179% year over year (YOY) in India, in...


135 job openings in over 60 companies are listed at our free Digital and Mobile Job Board: If you’re looking for a job, or...


Rajesh Kumar* doesn’t have many enemies in life. But, Uber, for which he drives a cab everyday, is starting to look like one, he...


By Aroon Deep and Aditya Chunduru You’re reading it here first: Twitter has complied with government requests to censor 52 tweets that mostly criticised...

MediaNama is the premier source of information and analysis on Technology Policy in India. More about MediaNama, and contact information, here.

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ

Subscribe to our daily newsletter
Your email address:*
Please enter all required fields Click to hide
Correct invalid entries Click to hide

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ